Overview

Detailed Summary

Bajaj Healthcare Limited is a major pharmaceutical manufacturer specializing in APIs, finished dosage forms, and nutraceuticals. It operates 20 state-of-the-art manufacturing facilities and exports products to over 60 countries.
In FY 2025, Bajaj Healthcare achieved a total income of Rs 562.01 Cr, showcasing resilience amid challenging market conditions. The company maintains a net worth of Rs 486.39 Cr, illustrating a sound financial position.
Bajaj Healthcare's strategic acquisition of Genrx Pharmaceuticals Private Limited marks a significant growth step, reinforcing its market presence and operational capacities.
With a robust R&D pipeline, Bajaj Healthcare focuses on peptide synthesis and aims commercialization by March 2026, emphasizing its commitment to innovation and expanding global demand.
Its CDMO partnership with UK/EU clients highlights Bajaj Healthcare's strategic move to enhance international collaborations, ensuring a foothold in lucrative markets and exclusive medicinal manufacturing.

Sector: Pharmaceuticals & Biotechnology
Industry: Pharmaceuticals
Market Cap: 1,124 Cr
Volatility: High Risk
P/E Ratio: 21.8
Industry P/E: 32.2
PEG Ratio: 0.1
P/B Ratio: 2.2
52W High: 642.30
52W Low: 273.15

Sales CAGR

1Y: 14.61%
3Y: -7.24%
5Y: 5.76%
10Y: 10.39%

Profit CAGR

1Y: 147.14%
3Y: -15.59%
5Y: 11.21%
10Y: 20.19%

ROE

TTM: 10.52%
3Y: -0.11%
5Y: 9.02%
10Y: 9.69%

ROCE

TTM: 10.52%
3Y: 13.16%
5Y: 19.35%
10Y: 19.35%

Technicals

‌

Forecasts

Peers

Healthcare Healthcare Pharmaceuticals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
HESTERBIO		1429.05	1,257 Cr	28.62	3.72	0.47	12.98	9.93	6.29
JAGSNPHARM		190.30	1,244 Cr	31.38	4.92	1.33	17.30	21.58	13.68
LINCOLN		615.00	1,232 Cr	14.02	1.72	0.29	11.18	15.34	10.28
INDSWFTLAB		132.10	1,147 Cr	5.55	0.84	0.00	2.27	1.19	16.09
FREDUN		1820.00	1,140 Cr	28.07	4.45	0.03	22.85	26.16	7.04
BAJAJHCARE		315.70	1,124 Cr	21.79	2.24	0.28	10.52	10.52	5.94
ACCENTMIC		409.35	1,004 Cr	26.06	4.28	0.24	13.89	19.49	12.00
Median: 7 Co.	—	409.35	1,147 Cr	26.06	3.72	0.28	12.98	15.34	10.28

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	101	109	134	132	133	123	154	149	148	161
Expenses	82	89	118	108	109	101	143	124	121	131
Operating Profit	19	20	16	25	25	22	12	25	27	31
OPM %	18.72	17.99	11.98	18.53	18.43	17.62	7.61	16.47	18.21	19.03
Other Income	1.22	0.80	-38	0.85	2.61	2.37	14	0.88	1.65	1.65
Interest	8.26	6.65	6.01	8.44	7.88	5.51	6.08	5.23	5.56	5.88
Depreciation	6.66	7.35	7.30	6.73	6.81	6.85	7.53	5.64	7.08	7.20
Profit Before Tax	5.24	6.33	-35	10	12	12	12	15	16	19
Tax %	2.29	12.64	8.96	21.22	32.93	-28.41	1.11	16.17	21.99	16.32
Net Profit	5.12	5.52	-32	8.03	8.34	15	12	12	12	16
EPS in Rs	-1.02	-0.66	-9.50	2.12	3.15	3.42	3.25	3.42	3.26	4.57

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	231	327	370	410	657	680	646	473	543	559
Expenses	200	288	328	362	521	561	534	397	460	477
Operating Profit	31	39	43	48	136	119	111	76	82	82
OPM %	13.29	11.99	11.52	11.73	20.75	17.43	17.24	16.11	15.19	14.74
Other Income	2.39	2.07	0.97	6.53	6.91	1.44	1.59	-36	19	19
Interest	8.01	7.52	8.02	6.45	8.30	13	18	30	28	25
Depreciation	11	11	11	12	16	18	17	28	28	27
Profit Before Tax	14	23	24	36	119	90	78	-17	46	50
Tax %	42.84	33.05	32.52	30.02	30.05	20.40	18.74	14.09	6.69	6.51
Net Profit	7.82	15	16	25	83	71	64	-14	43	47
EPS in Rs	—	—	—	7.50	22.42	21.21	12.78	-9.09	11.94	14.49
Dividend Payout %	0.00	4.54	0.00	0.00	9.13	5.80	6.41	-3.29	7.62	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	6.75	6.90	6.90	6.90	14	14	14	14	14	16
Reserves	82	92	107	146	164	245	315	354	265	450
Borrowings	74	66	76	72	82	181	257	415	333	223
Other Liabilities	47	54	79	58	83	86	136	115	154	144
Total Liabilities	209	219	268	283	343	526	721	898	765	833
Fixed Assets	130	128	127	156	162	208	270	366	253	238
CWIP	1.46	0.23	1.97	1.18	5.45	57	52	22	6.62	3.45
Investments	0.00	0.00	0.00	0.00	5.00	0.00	0.00	0.00	0.00	0.00
Other Assets	78	91	140	126	170	260	399	510	506	591
Total Assets	209	219	268	283	343	526	721	898	765	833

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	25	22	17	25	21	44	0.69	-22	92	22
Cash from Investing Activity	-31	-8.45	-12	-13	-28	-109	-75	-93	-11	-15
Cash from Financing Activity	5.08	-13	2.47	-13	3.28	75	62	131	-97	-6.38
Net Cash Flow	-0.44	0.47	7.45	-0.42	-3.70	10	-12	16	-16	0.43

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	67.49%	67.69%	67.73%	67.73%	67.73%	59.19%	59.19%	59.19%	59.19%	59.19%	59.19%	58.29%
FIIs	0.69%	0.66%	0.74%	0.53%	0.01%	1.07%	1.01%	1.05%	1.09%	1.12%	1.18%	1.53%
DIIs	0.34%	0.44%	0.48%	0.44%	0.00%	1.97%	2.36%	2.52%	3.16%	3.00%	2.96%	2.91%
Public	31.48%	31.22%	31.06%	31.30%	32.26%	37.78%	37.45%	37.24%	36.56%	36.70%	36.67%	37.27%
Total Shareholders	27,322	28,008	29,626	32,712	32,397	31,993	32,672	35,710	35,980	38,574	37,953	37,696

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q2 FY26

Investor Presentation

Q4 FY24

Investor Presentation

Q4 FY22

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

Investor Presentation

Q1 FY21

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about Bajaj Healthcare Ltd

Bajaj Healthcare Ltd (BAJAJHCARE) is currently trading at 329.95 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Bajaj Healthcare Limited is a major pharmaceutical manufacturer specializing in APIs, finished dosage forms, and nutraceuticals. It operates 20 state-of-the-art manufacturing facilities and exports products to over 60 countries. In FY 2025, Bajaj Healthcare achieved a total income of Rs 562.01 Cr, showcasing resilience amid challenging market conditions. The company maintains a net worth of Rs 486.39 Cr, illustrating a sound financial position. Bajaj Healthcare's strategic acquisition of Genrx Pharmaceuticals Private Limited marks a significant growth step, reinforcing its market presence and operational capacities. With a robust R&D pipeline, Bajaj Healthcare focuses on peptide synthesis and aims commercialization by March 2026, emphasizing its commitment to innovation and expanding global demand. Its CDMO partnership with UK/EU clients highlights Bajaj Healthcare's strategic move to enhance international collaborations, ensuring a foothold in lucrative markets and exclusive medicinal manufacturing.

Over the past 52 weeks, Bajaj Healthcare Ltd has traded between a low of ₹273.15 and a high of ₹642.30. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Bajaj Healthcare Ltd has a market capitalization of approximately 1,123.83. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Bajaj Healthcare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 21.79 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 1,123.83 Cr, Bajaj Healthcare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Bajaj Healthcare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Bajaj Healthcare Ltd is 21.79. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The stock rallied after the company reported strong Q4FY26 earnings, including a sharp year-on-year rise in profit and a significant expansion in EBITDA and margins.

Bajaj Consumer Care reported an 83% year-on-year increase in consolidated net profit to ₹46.37 crore. Revenue from operations grew by 30.57% to ₹306.09 crore, and EBITDA margin expanded significantly to 18.3%.

The stock surged 20% after the company reported strong financial results for the third quarter of FY26, including an 83% increase in net profit and a 31% rise in revenue.

Bajaj Healthcare Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Forecasts

Peers

Price Chart Comparison

Financial Statements

AI Powered Summary

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Standalone Profit Loss (in ₹ Crores)

Standalone Balance Sheet (in ₹ Crores)

Standalone Cash Flows (in ₹ Crores)

Shareholdings

Shareholding History

Market Transactions

Unlock more with professional

Projection

Documents

Actions

Announcements

AI Mode

Ask AI

Frequently Asked Questions about Bajaj Healthcare Ltd

What is Bajaj Healthcare Ltd share price today?

What does Bajaj Healthcare Ltd do?

What is the 52-week high and low of Bajaj Healthcare Ltd?

What is the market capitalization of Bajaj Healthcare Ltd?

Should I consider investing in Bajaj Healthcare Ltd stock?

Is Bajaj Healthcare Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Bajaj Healthcare Ltd belong to and why does it matter?

What is the PE ratio of Bajaj Healthcare Ltd?

Why did Bajaj Consumer Care shares rise on April 17, 2026?

What were the key highlights of Bajaj Consumer Care's Q3 FY26 results?

Why did Bajaj Consumer Care's stock price increase by 20% on January 22, 2026?

Investor’s Suite

Market Explorer

Market Pulse

Deep Dive

Utility

Company

Technicals

Forecasts

Projection

Frequently Asked Questions about Bajaj Healthcare Ltd

What is Bajaj Healthcare Ltd share price today?

What does Bajaj Healthcare Ltd do?

What is the 52-week high and low of Bajaj Healthcare Ltd?

What is the market capitalization of Bajaj Healthcare Ltd?

Should I consider investing in Bajaj Healthcare Ltd stock?

Is Bajaj Healthcare Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Bajaj Healthcare Ltd belong to and why does it matter?

What is the PE ratio of Bajaj Healthcare Ltd?

Why did Bajaj Consumer Care shares rise on April 17, 2026?

What were the key highlights of Bajaj Consumer Care's Q3 FY26 results?

Why did Bajaj Consumer Care's stock price increase by 20% on January 22, 2026?

Announcements

Peers

Price Chart Comparison

Oscillators

Neutral

Overall

Bearish

Moving Averages

Bearish

Overall

Bearish

Overview

Financial Ratios

Investment Checklist